¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mass action theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • immediate action
    Áï½ÃÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • inotropic action
    ¼öÃàÃËÁøÀÛ¿ë
  • interferential action
    °£¼·ÀÛ¿ë
  • monophasic action potential
    ´Ü»óȰµ¿ÀüÀ§
  • nerve action potential
    ½Å°æÈ°µ¿ÀüÀ§
  • neurotropic action
    Çâ½Å°æÀÛ¿ë
  • photochemical action
    ±¤È­ÇÐÀÛ¿ë
  • polyphasic action potential
    ´Ù»óȰµ¿ÀüÀ§
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • promotor action
    ÃËÁøÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • reflex action
    ¹Ý»çÀÛ¿ë
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®
  • specific action
    ƯÀÌÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • action
    Ȱµ¿, ÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • amphoteric action
    ¾ç¼ºÀÛ¿ë
  • anabolic action
    µ¿È­ÀÛ¿ë
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • bacteriocidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë
  • buffer action
    ¿ÏÃæÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • antimicrobial action
    Ç×±ÕÀÛ¿ë(¡­íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°(¼º) ÀÛ¿ë(ù÷¡­(àõ) íÂéÄ).
  • antimuscarinic action
    Ç×¹«½ºÄ«¸°ÀÛ¿ë(ù÷¡­íÂéÄ).
  • antipyretic action
    ÇØ¿­ÀÛ¿ë(¡­íÂéÄ).
  • antispasmodic action
    Áø°æÀÛ¿ë(¡­íÂéÄ)
  • galvanic action
    °¥¹Ù´ÏÀÛ¿ë.
  • ganglionic blocking action
    ½Å°æÀýÂ÷´ÜÀÛ¿ë.
  • germicidal action
    »ì±ÕÀÛ¿ë(߯жíÂéÄ).
  • gestagenic action
    ÇÁ·ÎÁ¦½ºÅ×·ÐÀÛ¿ë(¡­íÂéÄ).
  • immediate action
    Áï°¢ÀÛ¿ë, Áï½ÃÀÛ¿ë.
  • indirect action
    °£Á¢ÀÛ¿ë.
  • indirect action
    °£Á¢ÀÛ¿ë
  • inhibitory action
    ÀúÁöÀÛ¿ë(îÁò­íÂéÄ).
  • inotropic action
    º¯·ÂÀÛ¿ë(ܨÕôíÂéÄ), ¼öÃàÃËÁøÀÛ¿ë(â¥õêõµòäíÂéÄ).³»°ú¼öÃà·Â
  • inotropic action
    º¯·ÂÀÛ¿ë, ¼öÃàÃËÁøÀÛ¿ë.[³»°ú]¼öÃà·Â º¯µ¿ÀÛ¿ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mass examination
    Áý´Ü°ËÁø, Áý´Ü°Ë»ç
  • mass gypsum
    ±«»ó¼®°í¿ø¼®(ÎÔßÒà´ÍÇê«à´).
  • mass infection
    Áý´Ü°¨¿°(̤ËÀ˧Ëç).
  • mass ligature
    Áý´Ü°áÂû(¹ý)(Áý´Ü°áÂû¹ý).
  • mass measurement
    Áú·®ÃøÁ¤
  • mass measurement technique
    Áú·®ÃøÁ¤±â¼ú
  • mass miniature radiography
    Áý´Ü Ãà¼Ò ¹æ»ç¼±ÃÔ¿µ¼ú (°£Á¢ÃÔ¿µ¼ú)
  • mass miniature radiography
    ¹æ»ç Áý´Ü°£Á¢¹æ»ç¼±¼ú(̤ËÀË§ËøËÑË×ËÛËà) X¼±Áý´Ü°ËÁø .
  • mass miniature roentgenography
    ¹æ»ç Áý´Ü°£Á¢ X¼±ÃÔ¿µ¼ú(̤ËÀË§ËøÊÙËÛ̧ËçËà).
  • mass movement
    Áý´Ü¿îµ¿(ó¢Ó¥ê¡ÔÑ).
  • mass murderer
    ´ë·®»ìÀÎÀÚ(ÓÞåÖ߯ìÑíº).
  • mass number
    Áú·®¼ö
  • mass number
    Áú·®¼ö(òõåÖâ¦).
  • mass peristalsis
    Áý´Ü¿¬µ¿(ó¢Ó¥æÀÔÑ).
  • mass polymerization
    ±«»óÁßÇÕ(ÎÔßÒñìùê).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • collision theory
    Ãæµ¹ÀÌ·Ð(õúÔÍ×âÖå)
  • convergence theory of cancer
    "¾Ï ¼ö·Å·Ð(äßâ¥Ö°Öå),(ÔÒ) Greenstein hypothesis"
  • crystal field theory
    °áÁ¤ Àå·Ð(Ì¿ïÜíÞÖå)
  • Ehrlich's receptor theory
    ¿¡¸¦¸®È÷ ¼ö¿ëüÀÌ·Ð(áôé»ô÷×âÖå)
  • elective theory
    ¼±Å÷Ð(àÔ÷ÉÖå)
  • error theory
    ¿À·ù ÀÌ·Ð (è¦×½×âÖå)
  • eversion theory
    ¿Ü¹øÀÌ·Ð (èâÛè×âÖå)
  • evolution theory
    ÁøÈ­·Ð(òäûùÖå)
  • exhaustion theory
    °í°¥ ÀÌ·Ð (ͽÊä×âÖå)
  • factor theory
    ÀÎÀÚ ÀÌ·Ð(ì×í­×âÖå)
  • fluctuation theory
    ¿äµ¿ ÀÌ·Ð(èôÔÑ×âÖå)
  • frozen accident theory
    »ç°í µ¿°á ÀÌ·Ð(ÞÀͺÔÐÌ¿×âÖå)
  • germ-line theory
    ¹èÀÚ°è¿­ ÀÌ·Ð(ÛÏí­Í§Öª×âÖå)
  • hit theory
    °¡°Ý ÀÌ·Ð(ʥ̪×âÖå)
  • imbalance theory
    ºÒ±ÕÇü ÀÌ·Ð(ÝÕгû¬×âÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
APA action potential amplitude; aldosterone-producing adenoma; Ambulatory Pediatric Association; America...
APD action potential duration; acute polycystic disease; advanced physical diagnosis; anteroposterior di...
BSAP brief short-action potential; brief, small, abundant potentials
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
CMAP compound muscle (or motor) action potential
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
APD90 action potential durations at 90% repolarization
CAP cochlea action potentials
CAP Compound Action Potential
CMAP Compound motor action potential
CMAP Compound muscle action potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Jackson's theory
    Àè½¼ ¼³
    ÀηùÀÇ ³ú¼ö´Â °¡Àå »óºÎ¿¡ ÀÖÀ»¼ö·Ï ÁøÈ­ÇÑ °ÍÀÌ´Ù.
  • Kubelka-Munk theory
    Äíº§Å°-¸ÛÅ©¼³
  • libido theory
    ¸®ºñµµ Çм³, ¼º¿å¼³
    S. ÇÁ·ÎÀÌÆ®´Â ¸®ºñµµ°¡ »çÃá±â¿¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀÌ ¾Æ´Ï¶ó ž¸é¼­ºÎÅÍ ¼­¼­È÷ ¹ß´ÞÇÏ´Â °ÍÀ̶ó°í »ý°¢ÇÏ¿´´Ù. Áï ¼º º»´ÉÀº ±¸¼ø±â, Ç×¹®±â¸¦ ÅëÇØ ¹ß´ÞÇÏ´Ù°¡ 5¼¼°æ ÀýÁ¤¿¡ À̸¥ ÈÄ, ¾ï¾ÐÀ» ¹Þ¾Æ ÀáÀç±â¿¡ À̸£°í, »çÃá±â¿¡ ´Ù½Ã ¼º¿åÀ¸·Î ³ªÅ¸³­´Ù°í ÇÑ´Ù. ±×·¯³ª ¸®ºñµµ´Â, Áßµµ¿¡¼­ ¹ß´ÞÀÌ ÁßÁöµÇ±âµµ Çϰí, ¿ÏÀüÈ÷ ¹ß´ÞÇß´Ù°¡ °Å²Ù·Î µÇµ¹¾Æ°¡´Â °æ¿ìµµ ÀÖ´Ù. ÀÌ»ó ¼º¿å
  • menophylectic theory
    ÀÏ¿ø¼³
  • MIE theory
    MIE ¼³
  • migration theory
    À̵¿¼³
  • monoclonal theory
    ´ÜÀÏ ¼¼Æ÷ À¯·¡¼³
  • oxidation theory
    »êÈ­¼³
  • polychromatic theory
    ´Ù»ö¼³
  • Prothero cone theory
    ÇÁ·Îµ¥·Î ÄÜ ¼³
  • psychological theory
    ½É¸®ÇÐ ÀÌ·Ð
  • psychosexual stage theory
    ½É¸® ¼ºÀû ´Ü°è ÀÌ·Ð
  • receptor theory
    ¼ö¿ë±â ÀÌ·Ð
    Ç×ü »ý¼º ¼¼Æ÷ÀÇ Ç¥¸é¿¡´Â ƯÁ¤ Ç×ü¿¡ »óÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇ϶ó ¼ö¿ëü°¡ Á¸ÀçÇÏ¸ç ±× ¼ö¿ëüÀÇ ±¸Á¶´Â Ç×üÀÇ ±¸Á¶¿Í °°´Ù´Â ÀÌ·Ð.
  • selection theory
    ¼±Åü³
  • symbiosis theory
    °ø»ý¼³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
mass screening Organised periodic procedures performed on large groups of people for the purpose of detecting disease.
(12 Dec 1998)
mass spectrograph An instrument that subjects charged and accelerated ions (atomic or molecular) to a magnetic field that imparts a curved path that differs for each mass-to-charge ratio, thus separating individual species; used in detecting and assaying isotopic ratios and in molecular structure determinations.
(05 Mar 2000)
mass stopping power <physics> The mass stopping power (S/r) of a material for charged particles is the quotient dEs by the product of dl and r, where dEs is the average energy lost by a charged particle of specified energy in traversing a path length dl and r is the density of the medium.
(16 Dec 1997)
MASS syndrome <syndrome> A syndrome closely resembling both the Marfan's syndrome and the Barlow syndrome. However, no dislocation of the lenses or aneurysmal changes occur in the aorta, and the mitral valve prolapse is by no means invariable. at present it has been assigned no separate OMIM number, but shares that of the Barlow syndrome.
Origin: mitral valve prolapse, aortic anomalies, skeletal changes, and skin changes.
(05 Mar 2000)
parotid gland mass <radiology> Pleomorphic adenoma, sialocele, adenoid cystic carcinoma, adenocarcinoma, lymphoma, lymph node, abscess, metastasis
(12 Dec 1998)
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
middle ear mass <radiology> Glomus tumour (multiple in 10%; 8% malignant), glomus tympanicum, from cochlear promontory, seldom erodes bone, glomus jugulare, invasion of middle ear from below, destruction of bony roof of jugular fossa and bony spur separating vein from carotid artery, abberant carotid artery (no bony margin), enlarged jugular bulb (dehiscent bony covering), cholesteatoma, rhabdomyosarcoma (orbit greater than nasopharynx greater than ear), adenocarcinoma (rare)
(12 Dec 1998)
middle mediastinal mass <radiology> Mnemonic: not VD, 90% malignant, Nodes, tumour (metastasis, lymphoma/leukaemia), infection, inhalational disease, Castleman disease, Tumour, primary lung, trachea, oesophagus carcinoma, Vascular, aneurysm, haematoma, Duplication cyst, bronchogenic, enteric, neurenteric
(12 Dec 1998)
molar mass See: molecular weight.
(05 Mar 2000)
molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
pill mass The mixture of drug(s), excipients, diluents and binders with a suitable amount of liquid to form a plastic mass which can be rolled into a long rod and cut into the appropriate number of units for pills to be rolled from.
Synonym: pill mass.
(05 Mar 2000)
pilular mass The mixture of drug(s), excipients, diluents and binders with a suitable amount of liquid to form a plastic mass which can be rolled into a long rod and cut into the appropriate number of units for pills to be rolled from.
Synonym: pill mass.
(05 Mar 2000)
complex liver mass in kids <radiology> Epithelial, FNH (uncommon, F greater than M), hepatic adenoma (uncommon, F greater than M), hepatoma (increased aFP in 90%), hepatoblastoma (increased aFP, less than 2 years of age), mesenchymal, hamartoma, cavernous haemangioma, haemangioendothelioma, embryonal rhabdomyosarcoma (obstructs common bile duct; less than 5 years of age), undifferentiated sarcoma, teratoma, abscess / haematoma / complicated cyst
(12 Dec 1998)
critical mass <chemistry, radiobiology> The minimum amount of mass of a combination of radioactive substances needed for the substances to generate and lose an exactly balanced number of neutrons to make a chain reaction which will keep going by itself.
(09 Oct 1997)
posterior mediastinal mass <radiology> Mnemonic: HALOVEEN, haematoma, abscess, lymph nodexs, osteophyte, vertebral (metastasis, plasmacytoma), extramedullary haematopoesis, oesophagus, neurogenic
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • stress theory
    (ij³ª´ÙÀÇ H,Selye ±³¼ö ÁÖâÀÇ)½ºÆ®·¹½º Çм³
  • theory
    Çм³;¼³;ÀÌ·Ð;(Ź»óÀÇ)°ø·Ð
  • transformation theory
    º¯Çü¼³
  • trickledown theory
    Æ®¸®Å¬´Ù¿î ÀÌ·Ð(´ë±â¾÷¿¡ÀÇ ÀçÁ¤Àû ¿ì´ë´Â Áß¼Ò±â¾÷À̳ª ¼ÒºñÀÚ¿¡°Ô ÆÄ±ÞÈ¿°ú¸¦ Áشٴ ¼³)
  • mass
    µ¢¾î¸®,´ëÁß,Áý´Ü,´Ù·®,¹Ì»ç
  • Dialogue Mass
    (õÁÖ±³)´ëÈ­ ¹Ì»ç
  • Low Mass
    Æò¹Ì»ç
  • Mass book
    ¹Ì»ç Àü·Ê¼­
  • atomic mass
    ¿øÀÚ Áú·®
  • atonic mass
    ¿øÀÚÁú·®
  • critical mass
    ÀÓ°è Áú·®;¹Ù¶÷Á÷ÇÑ °á°ú¸¦ È¿°úÀûÀ¸·Î ¾ò±âÀ§ÇÑ ÃæºÐÇÑ ¾ç
  • folk mass
    Æ÷Å© ¹Ì»ç(ÀüÅëÀû À½¾Ç´ë½Å Æ÷Å© ¹ÂÁ÷À» °çµéÀÌ´Â ¹Ì»ç)
  • high Mass
    (Ä«Å縯) Àå¾öÇÑ ¹Ì»ç
  • mass
    µ¢¾î¸®;Áý´Ü;´Ù¼ö;´Ù·®(He is a ~ of bruises Àü½Å »óó Åõ¼ºÀÌ´Ù);ŹÝ;Áú·® in the ~ ÅëÆ²¾î;the (great) ~ of ...ÀÇ ´ëºÎºÐ;the ~es ´ëÁß
  • mass
    ¹Ì»ç(Ä«Å縯±³ÀÇ ¼ºÃ¼ ¼º»ç);¹Ì»ç°î High Mass (ºÐÇâ,ÁÖ¾ÇÀÌ ÀÖ´Â) ´ë¹Ì»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á